Alerts will be sent to your verified email
Verify Email
THEMISMED
|
Themis Medicare
|
Kopran
|
Hester Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
3.59 % | n/a | 1.53 % |
|
Financials
|
|||
|
5 yr Average ROE
|
16.7 % | 13.42 % | 12.14 % |
|
5yr average Equity Multiplier
|
1.64 | 1.63 | 2.11 |
|
5yr Average Asset Turnover Ratio
|
0.69 | 0.91 | 0.45 |
|
5yr Avg Net Profit Margin
|
14.74 % | 8.88 % | 12.98 % |
|
Price to Book
|
3.04 | 1.71 | 5.02 |
|
P/E
|
40.99 | 23.01 | 57.37 |
|
5yr Avg Cash Conversion Cycle
|
83.02 Days | 93.5 Days | 83.43 Days |
|
Inventory Days
|
75.24 Days | 83.24 Days | 106.53 Days |
|
Days Receivable
|
154.39 Days | 111.32 Days | 94.77 Days |
|
Days Payable
|
149.43 Days | 87.92 Days | 142.53 Days |
|
5yr Average Interest Coverage Ratio
|
6.9 | 10.26 | 7.46 |
|
5yr Avg ROCE
|
18.52 % | 18.18 % | 12.53 % |
|
5yr Avg Operating Profit Margin
|
19.18 % | 13.87 % | 24.84 % |
|
5 yr average Debt to Equity
|
0.34 | 0.26 | 0.74 |
|
5yr CAGR Net Profit
|
11.92 % | 19.38 % | -8.32 % |
|
5yr Average Return on Assets
|
10.34 % | 8.15 % | 5.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.15 % | 44.42 % | 53.73 % |
|
Share Pledged by Promoters
|
2.43 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.03 % | 0.17 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.03 % |
|
Themis Medicare
|
Kopran
|
Hester Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Verticals
|
Verticals
|
-
|
-
|